Sugi Predict

Sugi Predict / Compounds / SCHEMBL487276

SCHEMBL487276

SCHEMBL487276

O=c1[nH]cccc1[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.59
▸ TDP1 Q9NUW8 4/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ GPR35 Q9HC97 1/20 0.45
▸ DAO P14920 1/20 0.45
▸ AURKA O14965 1/20 0.45
▸ AURKB Q96GD4 1/20 0.45
▸ INCENP Q9NQS7 1/20 0.45
▸ PARP1 P09874 1/20 0.44
▸ S100A4 P26447 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ TSHR P16473 2/20 0.42
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3831213 0.89 AURKA (0.66) ALDH1A1TDP1KDM4EGPR35DAO
SCHEMBL27865554 0.89 FKBP5 (0.55) ALDH1A1TDP1KDM4EGPR35DAO
SCHEMBL28785343 0.77 TDP1 (0.55) ALDH1A1TDP1KDM4EPARP1S100A4
SCHEMBL29154779 0.77 ALDH1A1 (0.50) ALDH1A1TDP1KDM4EGPR35PARP1
SCHEMBL1136675 0.77 TDP1 (0.45) ALDH1A1TDP1KDM4EGPR35S100A4
SCHEMBL17802800 0.77 TDP1 (0.45) ALDH1A1TDP1KDM4EGPR35S100A4
SCHEMBL307488 0.75 ALDH1A1 (1.00) ALDH1A1TDP1KDM4EPARP1HSD17B10
SCHEMBL30098446 0.75 ALDH1A1 (1.00) ALDH1A1TDP1KDM4EPARP1HSD17B10
SCHEMBL7423121 0.74 ALDH1A1 (0.58) ALDH1A1TDP1KDM4EGPR35PARP1
SCHEMBL1545421 0.72 ALDH1A1 (0.53) ALDH1A1TDP1KDM4EGPR35DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117624126-A Selective tyrosine kinase 2 (TYK 2) inhibitor compound, synthesis method and application 中国药科大学 2024-03-01 — — CN claimed
CN-102532010-B Preparation method of 2-chloro-3-aminopyridine JIANGSU XINHAN CO LTD 2013-12-04 — — CN claimed
EP-0843663-B9 4-ARYL-THIO-PYRIDIN-2(1H)-ONES, DRUGS CONTAINING SAME, AND USES THEREOF FOR TREATING HIV-RELATED DISEASES CENTRE NAT RECH SCIENT (FR) 2003-10-29 — — EP claimed
EP-0843663-B1 4-ARYL-THIO-PYRIDIN-2(1H)-ONES, DRUGS CONTAINING SAME, AND USES THEREOF FOR TREATING HIV-RELATED DISEASES CENTRE NAT RECH SCIENT (FR) 2003-04-09 — — EP claimed
EP-0843663-A1 4-ARYL-THIO-PYRIDIN-2(1H)-ONES, DRUGS CONTAINING SAME, AND USES THEREOF FOR TREATING HIV-RELATED DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1998-05-27 — — EP claimed
WO-1997005113-A1 4-ARYL-THIO-PYRIDIN-2(1H)-ONES, DRUGS CONTAINING SAME, AND USES THEREOF FOR TREATING HIV-RELATED DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1997-02-13 — — WO claimed
JP-4253975-A — — None — — JP disclosed
US-20260116857-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS PARDES BIOSCIENCES INC (US) 2026-04-30 — — US disclosed
US-20260062412-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY CHUGAI PHARMACEUTICAL CO LTD (JP) 2026-03-05 — — US disclosed
US-20250368613-A1 IRAK4 Inhibitors ASTRAZENECA AB (SE) 2025-12-04 — — US disclosed
EP-4647424-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-11-12 — — EP disclosed
EP-4642777-A1 INHIBITORS OF KIF18A AND USES THEREOF Insilico Medicine IP Limited (HK) 2025-11-05 — — EP disclosed
EP-4267574-B1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS INC (US) 2025-04-23 — — EP disclosed
US-4361638-A AMORPHOUS SILICON AND CARBON BASE MATERIAL DOPED WITH HYDROGEN AND FLUORINE FUJI PHOTO FILM CO., LTD. (JP) 1982-11-30 — — US disclosed
US-4225715-A Preparation of 3-amino(or carbamyl)-5-(pyridinyl)-2(1H)-pyridinones STERLING DRUG INC. (US) 1980-09-30 — — US disclosed
US-4199586-A Di-(lower-alkyl) N-[1,2-dihydro-2-oxo-5-(pyridinyl)-3-pyridinyl]amino-methylanemalonates STERLING DRUG INC. (US) 1980-04-22 — — US disclosed
US-4137233-A 1,2-Dihydro-2-oxo-5-(pyridinyl)nicotinamides STERLING DRUG INC. (US) 1979-01-30 — — US disclosed
US-4107315-A 5-(Pyridinyl)-2(1H)-pyridinones STERLING DRUG INC. (US) 1978-08-15 — — US disclosed
US-4072746-A CARDIOTONIC AGENTS STERLING DRUG INC. (US) 1978-02-07 — — US disclosed
US-4004012-A 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones STERLING DRUG INC. (US) 1977-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368613-A1 IRAK4 Inhibitors IRAK4, IRAK2, IRAK1 ALDH1A1 2671/4885TDP1 805/4885KDM4E 292/4885
US-20260116857-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS CTRC, CTRL, CTSL ALDH1A1 3293/4885TDP1 2135/4885KDM4E 2746/4885
US-20260062412-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY MYT1, NTMT1, MYL6 ALDH1A1 2880/4885TDP1 1883/4885KDM4E 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.